Join
Live feed
·
PRReleasevia Quantisnow
Silo Pharma Inc. logo

Silo Pharma Positioned to Advance Treatment Targeting PTSD as President Trump Signs Executive Order Aimed at Accelerating Research and Treatment Based Upon Psychedelics

ByQuantisnow·Wall Street's wire, on your screen.
Consumer Discretionary

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SILO (Silo Pharma Inc.) and more on Quantisnow.